FDA Approves Durvalumab With Enfortumab Vedotin-Ejfv For Muscle-Invasive Bladder Cancer

Benzinga Newsdesk · Nov 13, 2026 ·2 hours ago

FDANewsGeneral

https://www.fda.gov/drugs/cancer-approvals/fda-approves-durvalumab-enfortumab-vedotin-ejfv-muscle-invasive-bladder-cancer

Read the original